Development of anecortave acetate for the reduction of intraocular pressure (IOP) associated with glaucoma has been discontinued.

Link:http://invest.alconinc.com/phoenix.zhtml?c=130946&p=RssLanding&cat=news&id=1304229
Source:Alcon